Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology

Harry E. Peery, Gregory S. Day, Shannon Dunn, Marvin J. Fritzler, Harald Prüss, Claire De Souza, Asif Doja, Karen Mossman, Lothar Resch, Chenjie Xia, Boris Sakic, Larry Belbeck, Warren G. Foster

Research output: Contribution to journalReview articlepeer-review

119 Scopus citations


Anti-NMDAR encephalitis is a newly characterized syndrome with a progressive, predictable clinical course and the possibility of effective treatment. Accurate and timely diagnosis is critical to selection and implementation of treatments, and optimal patient outcomes. Outcomes are improved with early diagnosis via indirect immunofluorescence or cell-based assays, and the rapid and appropriate administration of immunosuppressant and anti-psychotic therapies. Three possible scenarios accounting for the immunopathogenesis of anti-NMDAR encephalitis are presented, with the most probable one being that of paraneoplastic autoimmunity. Future efforts in this disorder should focus on elucidating the mechanisms that contribute to initiation of this antibody response, as well as exploring the role of tumors, infectious triggers and immune-reactivation. Finally, accessible tools need to be developed that allow for reliable identification of specific antibody markers against synaptic proteins.

Original languageEnglish
Pages (from-to)863-872
Number of pages10
JournalAutoimmunity Reviews
Issue number12
StatePublished - Oct 2012


  • Anti-NMDA receptor
  • Cell based assay
  • Encephalitis
  • Neuroautoimmune disease
  • Psychosis
  • Seizures


Dive into the research topics of 'Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology'. Together they form a unique fingerprint.

Cite this